首页> 外文期刊>Journal of Cancer Research and Treatment >Histone Deacetylase Inhibitors: A Hope for Cancer Patients
【24h】

Histone Deacetylase Inhibitors: A Hope for Cancer Patients

机译:组蛋白脱乙酰基酶抑制剂:癌症患者的希望

获取原文
       

摘要

Cancer is a disease caused by genetic and genomic alterations such as amplifications, translocations, deletions or point mutations. Also, cancer development is caused by epigenetic changes due to modifications such as post-translational histone acetylations that can alter DNA and chromatin structures without alterations in the DNA sequence. Histones are the primary protein component of chromatin. It plays an important role in the interactions between the nucleosomes and within the nucleosome itself. Histone deacetylase enzyme is found in the nucleus of the different body cells and plays a vital role in remodeling of chromatin structure and controlling gene expression. Also, it was found to play an important role in the development of cancer. Histone deacetylase inhibitors which are used mainly in psychiatry and neurology may represent a new hope for cancer therapy. They act by various mechanisms which may help in prevention and treatment of cancer. Their combination with various lines of cancer therapy may represent a new hope for cancer patients.
机译:癌症是由遗传和基因组改变(例如扩增,易位,缺失或点突变)引起的疾病。同样,癌症的发展是由于表观遗传学变化所引起的,这些变化是由于修饰,例如翻译后组蛋白乙酰化,可以改变DNA和染色质结构而不会改变DNA序列。组蛋白是染色质的主要蛋白质成分。它在核小体之间以及核小体自身内部的相互作用中起着重要作用。组蛋白脱乙酰基酶存在于不同体细胞的细胞核中,在染色质结构重塑和基因表达控制中起着至关重要的作用。另外,发现它在癌症的发展中起重要作用。主要用于精神病学和神经病学的组蛋白脱乙酰基酶抑制剂可能代表了癌症治疗的新希望。它们通过各种机制起作用,可能有助于预防和治疗癌症。它们与各种癌症治疗方法的结合可能为癌症患者带来新的希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号